Sanchez L A, Suggs W D, Marin M L, Lyon R T, Parsons R E, Veith F J
Department of Surgery, Montefiore Medical Center, New York, 10467, USA.
J Vasc Surg. 1996 Feb;23(2):329-35. doi: 10.1016/s0741-5214(96)70278-1.
The purpose of this study was to evaluate the merit of polytetrafluoroethylene (PTFE) extensions and interpositions for the management of failing infrainguinal vein bypass grafts.
The treatment of 133 failing vein grafts in 125 patients over a 10-year period was retrospectively reviewed. Twenty-two graft-threatening lesions were detected in patients who did not have a usable autogenous vein conduit as determined by preoperative and intraoperative evaluations. A PTFE extension or interposition graft was used for the necessary reconstruction in all cases.
Ten lesions were within the vein graft, 11 were proximal to the graft in the femoral or popliteal artery segments, and one was distal to the graft in the popliteal artery. The treatment of these lesions included 19 extensions and three mid graft interpositions. The vein graft lesions developed significantly sooner (mean 10.6+/-2.5 months) after the bypass (p<0.05) than the arterial lesions (mean 28.0+/-6.1 months). The 3-year cumulative secondary patency rate for these vein grafts treated with PTFE extensions or interpositions was 84%+/-8%. This was not significantly different from the 3-year cumulative secondary patency rate for vein grafts treated with vein extensions or interpositions at our institution over the same time period (82%+/-10%). The 3-year limb salvage rates were 95% and 89%, respectively.
These results indicate that PTFE extensions and interpositions can be used successfully to maintain the patency of failing vein grafts and may serve to prolong limb salvage in patients without any usable autogenous vein. Early reintervention with a PTFE conduit in this difficult group of patients is appropriate to salvage a failing vein graft.
本研究旨在评估聚四氟乙烯(PTFE)延长段和置入物在处理失败的股腘静脉旁路移植血管方面的价值。
回顾性分析125例患者在10年期间133条失败的静脉移植血管的治疗情况。通过术前和术中评估确定,22例患者存在威胁移植血管的病变,且没有可用的自体静脉管道。所有病例均使用PTFE延长段或置入物进行必要的重建。
10处病变位于静脉移植血管内,11处位于移植血管近端的股动脉或腘动脉段,1处位于移植血管远端的腘动脉。这些病变的治疗包括19次延长和3次移植血管中段置入。静脉移植血管病变在旁路手术后出现的时间(平均10.6±2.5个月)明显早于动脉病变(平均28.0±6.1个月)(p<0.05)。接受PTFE延长段或置入物治疗的这些静脉移植血管的3年累积二次通畅率为84%±8%。这与同期在我们机构接受静脉延长段或置入物治疗的静脉移植血管的3年累积二次通畅率(82%±10%)无显著差异。3年肢体挽救率分别为95%和89%。
这些结果表明,PTFE延长段和置入物可成功用于维持失败静脉移植血管的通畅,并可能有助于延长没有可用自体静脉患者的肢体挽救时间。对于这一困难患者群体,早期使用PTFE管道进行再次干预以挽救失败的静脉移植血管是合适的。